London, UK (PRWEB) August 03, 2015
To date, many pharmaceutical and biotech companies outsource their R&D services to contract research organisations (CROs) for a slew of benefits, allowing them to gain access to capabilities that cannot be found in-house, enhance their global research and operations, boost quality with cost-effective utilisation of resources, get access to innovation and ensure timely introduction of product into the market. Additionally, these pharmacos and biotech companies have been increasing their presence from pole to pole, making the global outsourcing model for R&D activities widely accepted. The developing markets of India, Brazil, China, Eastern Europe and Latin America are deemed as targeted regions for growth in the CROs marketplace.
The global CRO market is expected to gain momentum going forward, driven by pricing pressures in the health care markets, the massive number of patent expirations, the demand for R&D productivity, and tight regulatory policies for the drug approvals, among others. The rise of outsourcing R&D activities by pharmacos as well as companies’ increased focus on their core activities to achieve cost efficiency of their operations.
However, the market for CROs is facing a slew of serious challenges that could restrain its growth. These include tight regulatory compliance for product approvals, dearth of competent specialists to perform R&D activities and also the increasing number of product recalls from the market owing to serious health complications of the newly approved drug molecules.
New market research report “Global Clinical Trial Outsourcing Report” created by Aniruddha Sowale is now available at MarketPublishers.com.
Title: Global Clinical Trial Outsourcing Report
Published: June, 2015
Price: US$ 4,000.00
The research report offers an up-close look at global CRO market. The study contains a qualitative analysis of the market, offering an overview of the drug discovery and development process, identifying key market drivers and restraints, value chain analysis, Porter’s five forces analysis, key M&A trends and strategic partnerships. A detailed segmentation of the market is provided by type of service, therapeutic area, and by geography. The study also canvasses the competitive scenario as well as profiles the top 5 companies.
Companies mentioned are: Quintiles Transnational Holdings, Inc., PAREXEL International Corp., Covance Inc., PRA Health Sciences and PPDI.
- insightful review of the market space;
- shrewd insights into market dynamics;
- deep analysis of the value chain;
- Porter’s five forces analysis;
- granular market segmentation;
- leading company profiles;
- major M&A trends and strategic partnerships;
- and more.
More studies by the publisher can be found at Aniruddha Sowale page.